Novo Nordisk
Allegra Lord is a Senior Scientist at Novo Nordisk since August 2023, previously serving as a Senior Scientist and Program Lead at Cellarity from March 2021 to August 2023. Allegra's experience spans various roles including Scientist II and teaching faculty at DIS - Study Abroad, focusing on Tumor Biology and Oncology. Prior research at SciLifeLab involved pooled CRISPR-Cas9-mediated genetic screens, while postdoctoral work at Karolinska Institutet concentrated on pediatric acute lymphoblastic leukemia. Allegra earned a Ph.D. in Biological and Biomedical Sciences from Harvard Medical School after completing an A.B. in Biology at Smith College.
This person is not in any teams
This person is not in any offices